In this issue:
Clinical characteristics of COVID-19 in China
COVID-19 clinical course and risk factors for mortality in Wuhan, China
Estimating risk for death from COVID-19, China, January-February 2020
Association of home NIPPV with clinical outcomes in COPD
Pirfenidone in patients with unclassifiable progressive fibrosing ILD
Anti-influenza hIVIG for influenza A or B infection
Safety of targeted lung denervation for COPD
NK-1 antagonist orvepitant is an antitussive for chronic refractory cough
Accuracy of Xpert MTB/RIF ultra for the diagnosis of pleural TB
Metoprolol for the prevention of acute exacerbations of COPD
Please login below to download this issue (PDF)